Schepens Eye Research Institute, Massachusetts Eye and Ear and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
Instituto de Neurociencias de Alicante, Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas, and International Brain Research Organization, Alicante, Spain.
Ocul Surf. 2016 Apr;14(2):264-316. doi: 10.1016/j.jtos.2015.11.003. Epub 2016 Jan 14.
On March 21, 2015, a meeting was held in London, United Kingdom, to address the progress in targeting the unmet need for dry eye disease (DED) treatment. The meeting, which launched the i(2) = initiating innovation series, was sponsored by the Tear Film & Ocular Surface Society (TFOS; www.TearFilm.org) and supported by Dompé. The TFOS i(2) meeting was designed to review advances in the understanding of DED since publication of the 2007 TFOS International Dry Eye WorkShop (DEWS) report, and to help launch the highly anticipated sequel, DEWS II. The meeting was structured to discuss the scope of the DED problem, to review the clinical challenges of DED, and to consider the treatment challenges of DED. This article provides a synopsis of the presentations of this TFOS i(2) meeting.
2015 年 3 月 21 日，在英国伦敦举行了一次会议，旨在探讨针对干眼疾病（DED）治疗未满足需求的进展。该会议启动了 i(2)倡议创新系列，由泪膜和眼表面学会（TFOS；www.TearFilm.org）主办，由 Dompé 公司支持。TFOS i(2)会议旨在回顾自 2007 年 TFOS 国际干眼工作研讨会（DEWS）报告发表以来对 DED 的理解方面的进展，并帮助推出备受期待的续集 DEWS II。会议的结构旨在讨论 DED 问题的范围，审查 DED 的临床挑战，并考虑 DED 的治疗挑战。本文概述了 TFOS i(2)会议的演讲内容。
Ocul Surf. 2017-7-20
Ocul Surf. 2017-7-20
2025-1
Invest Ophthalmol Vis Sci. 2018-11-1
Ocul Surf. 2017-7-20
Cont Lens Anterior Eye. 2018-6-27
Ocul Surf. 2014-4
Med Hypothesis Discov Innov Ophthalmol. 2023-12-31
J Ocul Pharmacol Ther. 2023-11
Front Med (Lausanne). 2022-9-6
Exp Biol Med (Maywood). 2022-3
Int J Ophthalmol. 2021-4-18
Diagnostics (Basel). 2021-2-25
Zotero 插件